ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope

He, Ping; Liu, Banghui; Gao, Xijie; Yan, Qihong; Pei, Rongjuan; Sun, Jing; Chen, Qiuluan; Hou, Ruitian; Li, Zimu; Zhang, Yanjun; Zhao, Jincun; Sun, Hao; Feng, Bo; Wang, Qian; Yi, Haisu; Hu, Peiyu; Li, Pingchao; Zhang, Yudi; Chen, Zhilong; Niu, Xuefeng; Zhong, Xiaolin; Jin, Liang; Liu, Xiaofeng; Qu, Kun; Ciazynska, Katarzyna A.; Carter, Andrew P.; Briggs, John A. G.; Chen, Jizheng; Liu, Jinsong; Chen, Xinwen*; He, Jun*; Chen, Ling; Xiong, Xiaoli广州医学院; 中国科学院研究生院; 中国科学院; 1
Nature Microbiology2022-10DOI: 10.1038/s41564-022-01235-4
18被引7阅读
引用收藏
分享

摘要

Population antibody response is thought to be important in selection of virus variants. We report that SARS-CoV-2 infection elicits a population immune response that is mediated by a lineage of VH1-69 germline antibodies. A representative antibody R1-32 from this lineage was isolated. By cryo-EM, we show that it targets a semi-cryptic epitope in the spike receptor-binding domain. Binding to this non-ACE2 competing epitope results in spike destruction, thereby inhibiting virus entry. On the basis of epitope location, neutralization mechanism and analysis of antibody binding to spike variants, we propose that recurrent substitutions at 452 and 490 are associated with immune evasion of the identified population antibody response. These substitutions, including L452R (present in the Delta variant), disrupt interactions mediated by the VH1-69-specific hydrophobic HCDR2 to impair antibody-antigen association, enabling variants to escape. The first Omicron variants were sensitive to antibody R1-32 but subvariants that harbour L452R quickly emerged and spread. Our results provide insights into how SARS-CoV-2 variants emerge and evade host immune responses. @@@ Amino acid changes in a newly identified spike epitope enabled the Delta variant to evade a population antibody response.

学科与关键词

关键词
NEUTRALIZING ANTIBODIESCRYO-EMVACCINE
相关
加载中…
  • Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
    Yan, Qihong; Hou, Ruitian; Huang, Xiaohan; Zhang, Yanjun; He, Ping; Zhang, Yudi; Liu, Banghui; Wang, Qian; Rao, Haiyue; Chen, Xianying; Zhao, Xinwei; Niu, Xuefeng; Zhao, Jincun*; Xiong, Xiaoli*; Chen, Ling*Emerging Microbes & Infections, 2022, 11(1): 2749-2761.被引 5
  • A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein
    Zhang, Yuting; Wang, Dan; Xiang, Qi; Hu, Xiaohui; Zhang, Yuting; Wu, Lijie; Zhang, Zhaoyong; Wang, Yanqun; Zhao, Jincun; McCormick, Peter J.; Fu, Jinheng*; Fu, Yang*; Zhang, Jin*; Jiang, Haihai*; Li, Jian*Virology, 2024, 589: 109925.
  • Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization
    Xiong, Danyang; Zhao, Xiaoyu; Luo, Song; Cong, Yalong; Zhang, John Z. H.*; Duan, Lili*Journal of Physical Chemistry Letters, 2022, 13(26): 6064-6073.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Microbiology
发表日期
2022-10
卷期
第 7 卷, 第 10 期
页码
1635-+
DOI
10.1038/s41564-022-01235-4
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82041014, 2021000192]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29050701]; Guangzhou Science and Technology Program Key Projects [2021904020037]; Natural Science Fund of Guangdong Province [2021A1515011289]; State Key Lab of Respiratory Disease Open project [SKLRD-Z-202106]; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases [2019B121205010]; Zhongnanshan Medical Foundation of Guangdong Province [ZNSA-2022009]; Chinese Academy of Sciences and Bioland Laboratory (GRMH-GL)

作者

  • H

    He, Ping (第一作者)

    univ chinese acad sci · cas · chinese acad sci · guangzhou inst biomed & hlth

  • L

    Liu, Banghui

    cas · chinese acad sci · guangzhou inst biomed & hlth

查看全部 33 位作者收起作者
  • G

    Gao, Xijie

  • Y

    Yan, Qihong

    1 · guangzhou med univ · cas · chinese acad sci · guangzhou inst biomed & hlth

  • P

    Pei, Rongjuan

    chinese acad sci · wuhan inst virol

  • S

    Sun, Jing

    1 · guangzhou med univ

  • C

    Chen, Qiuluan

  • H

    Hou, Ruitian

    univ chinese acad sci · cas · chinese acad sci · guangzhou inst biomed & hlth · guangzhou med univ

  • L

    Li, Zimu

    cas · chinese acad sci · guangzhou inst biomed & hlth

  • Z

    Zhang, Yanjun

    1 · guangzhou med univ

  • Z

    Zhao, Jincun

    1 · guangzhou med univ

  • S

    Sun, Hao

    chinese acad sci · wuhan inst virol

  • F

    Feng, Bo

    huaqiao univ

  • W

    Wang, Qian

    1 · guangzhou med univ

  • Y

    Yi, Haisu

    1 · guangzhou med univ

  • H

    Hu, Peiyu

    cas · chinese acad sci · guangzhou inst biomed & hlth

  • L

    Li, Pingchao

    cas · chinese acad sci · guangzhou inst biomed & hlth

  • Z

    Zhang, Yudi

    cas · chinese acad sci · guangzhou inst biomed & hlth · univ chinese acad sci

  • C

    Chen, Zhilong

    huaqiao univ

  • N

    Niu, Xuefeng

    1 · guangzhou med univ

  • Z

    Zhong, Xiaolin

  • J

    Jin, Liang

  • L

    Liu, Xiaofeng

  • Q

    Qu, Kun

  • C

    Ciazynska, Katarzyna A.

  • C

    Carter, Andrew P.

  • B

    Briggs, John A. G.

  • C

    Chen, Jizheng

    cas · chinese acad sci · guangzhou inst biomed & hlth

  • L

    Liu, Jinsong

    cas · chinese acad sci · guangzhou inst biomed & hlth

  • C

    Chen, Xinwen (通讯)

    cas · chinese acad sci · guangzhou inst biomed & hlth · wuhan inst virol

  • H

    He, Jun (通讯)

    cas · chinese acad sci · guangzhou inst biomed & hlth

  • C

    Chen, Ling

    guangzhou med univ · cas · chinese acad sci · guangzhou inst biomed & hlth

  • X

    Xiong, Xiaoli

    cas · chinese acad sci · guangzhou inst biomed & hlth

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417